These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23174249)

  • 1. CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer.
    Desotelle J; Truong M; Ewald J; Weeratunga P; Yang B; Huang W; Jarrard D
    J Urol; 2013 Jan; 189(1):329-35. PubMed ID: 23174249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer.
    Burton ER; Gaffar A; Lee SJ; Adeshuko F; Whitney KD; Chung JY; Hewitt SM; Huang GS; Goldberg GL; Libutti SK; Kwon M
    Mol Cancer Res; 2011 Aug; 9(8):1126-38. PubMed ID: 21693594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
    Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
    Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of promoter non-CG methylation in prostate cancer.
    Truong M; Yang B; Wagner J; Desotelle J; Jarrard DF
    Epigenomics; 2013 Feb; 5(1):65-71. PubMed ID: 23414321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer epigenomics.
    Perry AS
    J Urol; 2013 Jan; 189(1):10-1. PubMed ID: 23063895
    [No Abstract]   [Full Text] [Related]  

  • 6. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG
    J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate Carcinogenesis.
    Porter CM; Haffner MC; Kulac I; Maynard JP; Baena-Del Valle JA; Isaacs WB; Yegnasubramanian S; De Marzo AM; Sfanos KS
    Am J Pathol; 2019 Nov; 189(11):2311-2322. PubMed ID: 31499027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant aberrant Filip1l DNA methylation detected in a murine model of cutaneous squamous cell carcinoma.
    Roth K; Coussement L; Knatko EV; Higgins M; Steyaert S; Proby CM; de Meyer T; Dinkova-Kostova AT
    EBioMedicine; 2021 May; 67():103383. PubMed ID: 34000624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel tumor markers in prostate, colon and breast cancer by unbiased methylation profiling.
    Chung W; Kwabi-Addo B; Ittmann M; Jelinek J; Shen L; Yu Y; Issa JP
    PLoS One; 2008 Apr; 3(4):e2079. PubMed ID: 18446232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
    Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
    Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [GSTP1 CpG island hypermethylation as a molecular marker of prostate cancer].
    Bastian PJ; Nakayama M; De Marzo AM; Nelson WG
    Urologe A; 2004 May; 43(5):573-9. PubMed ID: 15029477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of Filamin A interacting protein 1-like Is associated with promoter methylation and an invasive phenotype in breast, colon, lung and pancreatic cancers [corrected].
    Kwon M; Lee SJ; Reddy S; Rybak Y; Adem A; Libutti SK
    PLoS One; 2013; 8(12):e82620. PubMed ID: 24340050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation.
    Bastian PJ; Yegnasubramanian S; Palapattu GS; Rogers CG; Lin X; De Marzo AM; Nelson WG
    Eur Urol; 2004 Dec; 46(6):698-708. PubMed ID: 15548435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
    Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IGFBP7 promoter methylation and gene expression analysis in prostate cancer.
    Sullivan L; Murphy TM; Barrett C; Loftus B; Thornhill J; Lawler M; Hollywood D; Lynch T; Perry AS
    J Urol; 2012 Oct; 188(4):1354-60. PubMed ID: 22906661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.